Abbott Laboratories (ABT) FCF Margin (2009 - 2026)
Abbott Laboratories recorded quarterly FCF Margin of 8.2% in Q1 2026, down 64.2% quarter-over-quarter from 22.92% in Q4 2025, and down 80.0% year-over-year from 41.02% in Q1 2025.
Abbott Laboratories' FCF Margin history runs 18 years deep, the most recent figure standing at 8.2% for Q1 2026.
- In Q1 2026, FCF Margin fell 80.0% year-over-year to 8.2%; the TTM figure through Mar 2026 stood at 16.35% (up 63.0% YoY), while the FY2025 annual figure was 16.68%, up 154.0% from the prior year.
- FCF Margin came in at 8.2% for Q1 2026 at Abbott Laboratories, down from 22.92% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 22.92% in Q4 2025 to a low of 6.29% in Q1 2024.
- A 5-year average of 15.06% and a median of 14.66% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin slumped 1107 bps in 2023 and soared 722 bps in 2024, its largest moves.
- Abbott Laboratories' FCF Margin stood at 17.01% in 2022, then surged by 31 bps to 22.29% in 2023, then slipped by 12 bps to 19.57% in 2024, then climbed by 17 bps to 22.92% in 2025, then tumbled by 64 bps to 8.2% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 8.2%, 22.92%, and 20.15% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 15.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.20% |
| Dec 31, 2025 | 22.92% |
| Sep 30, 2025 | 20.15% |
| Jun 30, 2025 | 13.87% |
| Mar 31, 2025 | 9.01% |
| Dec 31, 2024 | 19.57% |
| Sep 30, 2024 | 20.21% |
| Jun 30, 2024 | 13.75% |
| Mar 31, 2024 | 6.29% |
| Dec 31, 2023 | 22.29% |
| Sep 30, 2023 | 12.98% |
| Jun 30, 2023 | 6.98% |
| Mar 31, 2023 | 7.83% |
| Dec 31, 2022 | 17.01% |
| Sep 30, 2022 | 22.22% |
| Jun 30, 2022 | 18.04% |
| Mar 31, 2022 | 14.66% |
| Dec 31, 2021 | 21.39% |
| Sep 30, 2021 | 20.50% |
| Jun 30, 2021 | 16.78% |
| Mar 31, 2021 | 21.42% |
| Dec 31, 2020 | 29.15% |
| Sep 30, 2020 | 17.73% |
| Jun 30, 2020 | 9.28% |
| Mar 31, 2020 | 4.59% |
| Dec 31, 2019 | 23.84% |
| Sep 30, 2019 | 19.16% |
| Jun 30, 2019 | 7.42% |
| Mar 31, 2019 | 5.00% |
| Dec 31, 2018 | 16.72% |
| Sep 30, 2018 | 23.89% |
| Jun 30, 2018 | 12.18% |
| Mar 31, 2018 | 11.27% |
| Dec 31, 2017 | 17.06% |
| Sep 30, 2017 | 25.51% |
| Jun 30, 2017 | 16.51% |
| Mar 31, 2017 | 4.77% |
| Dec 31, 2016 | 15.96% |
| Sep 30, 2016 | 17.07% |
| Jun 30, 2016 | 12.41% |
| Mar 31, 2016 | -6.88% |
| Dec 31, 2015 | 11.18% |
| Sep 30, 2015 | 15.22% |
| Jun 30, 2015 | 14.02% |
| Mar 31, 2015 | -4.76% |
| Dec 31, 2014 | 17.76% |
| Sep 30, 2014 | 18.19% |
| Jun 30, 2014 | 12.70% |
| Mar 31, 2014 | 1.70% |
| Dec 31, 2013 | 26.06% |
| Sep 30, 2013 | 5.10% |
| Jun 30, 2013 | 8.64% |
| Mar 31, 2013 | 3.84% |
| Dec 31, 2012 | 19.83% |
| Sep 30, 2012 | 56.77% |
| Jun 30, 2012 | 30.90% |
| Mar 31, 2012 | 33.53% |
| Dec 31, 2011 | 10.86% |
| Sep 30, 2011 | 26.51% |
| Jun 30, 2011 | 22.15% |
| Mar 31, 2011 | 17.91% |
| Dec 31, 2010 | 20.32% |
| Sep 30, 2010 | 27.01% |
| Jun 30, 2010 | 23.51% |
| Mar 31, 2010 | 16.60% |
| Dec 31, 2009 | 18.06% |
| Sep 30, 2009 | 34.80% |